Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing. Mirae Asset Venture Investment and GNTech Venture Capital led the round.
Source: Press Release
Hummingbird Bioscience reels in $19 mln Series B
Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: